Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-13 4:08 pm Purchase |
2025-01-06 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 9,000,000 5.240% |
8,100,000 (+900.00%) |
Filing History |
| 2024-12-23 4:42 pm Purchase |
2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 14,116,000 9.870% |
14,116,000 (New Position) |
Filing History |
| 2024-12-23 4:41 pm Purchase |
2024-12-19 | 13G | 89bio, Inc. ETNB |
Deep Track Capital, LP | 6,477,949 5.410% |
4,477,949 (+223.90%) |
Filing History |
| 2024-11-22 4:16 pm Sale |
2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,000,000 4.820% |
-220,265 (-3.54%) |
Filing History |
| 2024-11-22 08:47 am Purchase |
2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,220,265 5.000% |
6,220,265 (New Position) |
Filing History |
| 2024-11-14 10:19 am Sale |
2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 0 0.000% |
-3,710,412 (Position Closed) |
Filing History |
| 2024-11-14 10:18 am Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 1,000,000 2.220% |
-1,323,456 (-56.96%) |
Filing History |
| 2024-11-14 10:00 am Sale |
2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL |
Deep Track Capital, LP | 1,553,996 3.920% |
-2,095,730 (-57.42%) |
Filing History |
| 2024-11-14 09:47 am Sale |
2024-09-30 | 13G | Verona Pharma plc VRNA |
Deep Track Capital, LP | 25,440,200 3.910% |
-7,492,192 (-22.75%) |
Filing History |
| 2024-11-14 09:46 am Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 531,857 0.700% |
-6,990,424 (-92.93%) |
Filing History |
| 2024-11-14 09:45 am Sale |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
Deep Track Capital, LP | 0 0.000% |
-1,815,854 (Position Closed) |
Filing History |
| 2024-11-14 09:44 am Sale |
2024-09-30 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 1,000,000 1.970% |
-1,184,440 (-54.22%) |
Filing History |
| 2024-11-14 09:44 am Sale |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 3,000,000 2.140% |
-2,854,740 (-48.76%) |
Filing History |
| 2024-11-14 09:42 am Sale |
2024-09-30 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 0 0.000% |
-2,992,731 (Position Closed) |
Filing History |
| 2024-11-14 09:41 am Sale |
2024-09-30 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 674,833 2.240% |
-1,369,674 (-66.99%) |
Filing History |
| 2024-11-14 09:39 am Sale |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 0 0.000% |
-1,793,966 (Position Closed) |
Filing History |
| 2024-11-14 09:38 am Sale |
2024-09-30 | 13G | Orchard Therapeutics plc ORTX |
Deep Track Capital, LP | 0 0.000% |
-19,125,150 (Position Closed) |
Filing History |
| 2024-11-14 09:36 am Sale |
2024-09-30 | 13G | HilleVax, Inc. HLVX |
Deep Track Capital, LP | 0 0.000% |
-2,900,000 (Position Closed) |
Filing History |
| 2024-11-14 09:31 am Sale |
2024-09-30 | 13G | Geron Corporation GERN |
Deep Track Capital, LP | 7,575,049 1.260% |
-22,008,400 (-74.39%) |
Filing History |
| 2024-11-14 09:29 am Sale |
2024-09-30 | 13G | Climb Bio, Inc. CLYM |
Deep Track Capital, LP | 2,169,143 3.230% |
-1,735,642 (-44.45%) |
Filing History |